YIDU TECH (02158) experienced a significant rise of over 7% during afternoon trading. At the time of writing, the stock was up 7.17%, trading at HK$6.13 with a turnover of HK$76.0051 million. The surge follows announcements that its subsidiary, Yidu Cloud (Beijing) Technology Ltd., has recently secured two major projects. The Artificial Intelligence Development Bank-Hospital Cooperation Project for Beijing Cancer Hospital has a total contract value of approximately RMB 4.88 million. Separately, the Hainan Province Integrated Regional Infectious Disease Surveillance, Early Warning, and Emergency Command Information Platform (Phase II) project is valued at around RMB 12.89 million. Analysts noted that these consecutive project awards demonstrate the strong competitiveness of YIDU TECH's "AI Medical Brain," YiduCore, in specialized verticals. The Hainan infectious disease surveillance project represents a second-phase development of a provincial-level public health platform, indicating continued government recognition of the company's digital capabilities for public health emergency management systems. The Beijing Cancer Hospital project marks another significant breakthrough for the company in the specialized field of oncology AI, with the bank-hospital cooperation model pioneering new commercial pathways for AI-powered medical services. With the ongoing implementation of policies related to "Data Elements x Healthcare," the company is well-positioned to benefit from the continued wave of investment in medical AI infrastructure development.